Pharmicell Co., Ltd.

KRX:005690.KS

5210 (KRW) • At close November 8, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Omzet 56,227.37960,181.80750,893.54637,752.04832,481.96728,351.80125,197.45927,839.15625,176.2820,155.40833,405.39411,111.810,282.4246,368.847,188.4258,327.60512,262.427
Kosten van de omzet 41,272.19136,362.21327,437.92919,972.75719,450.78216,548.11517,128.5417,622.29219,624.94916,307.55124,655.5679,783.54711,908.7284,641.8395,062.1656,244.6037,027.557
Brutowinst 14,955.18823,819.59423,455.61717,779.29113,031.18511,803.6868,068.91910,216.8645,551.3313,847.8578,749.8271,328.253-1,626.3041,727.0012,126.262,083.0025,234.87
Brutowinstmarge 0.2660.3960.4610.4710.4010.4160.320.3670.220.1910.2620.12-0.1580.2710.2960.250.427
Onderzoek- en ontwikkelingskosten 6,861.3096,884.2766,994.1594,308.4494,873.2534,505.043,602.7912,734.1421,756.9861,219.391762.26418.36366.6010000
Algemene en administratieve kosten 1,620.3891,504.934384.599347.76448.877551.107483.142605.893726.775670.5681,207.6921,083.5831,034.714597.63266.686241.777336.047
Verkoop- en marketingkosten 1,345.781908.5291,678.1191,160.291,212.9722,126.91,587.0031,869.7691,484.2482,677.9252,823.233,375.8933,636.4612,964.6732,001.9973,030.1184,381.629
Verkoop-, algemene en administratieve kosten 7,142.8822,413.4632,062.7181,508.051,661.8492,678.0072,070.1452,475.6622,211.0233,348.4934,030.9224,459.4764,671.1753,562.3032,268.6833,271.8954,717.676
Overige kosten 1,165.3835,648.4886,788.0794,729.2824,532.498-36.317.349838.852-818.234-3,086.557182.242-257.075108.972-1,131.402400.599540.6821,657.694
Bedrijfskosten 14,004.19114,946.22715,844.95610,545.78111,067.611,543.50712,528.17112,082.55511,083.34312,265.23716,386.79715,360.48713,567.96410,917.6834,613.0245,422.8037,299.204
Bedrijfsresultaat 950.9968,873.3677,610.6177,233.3791,963.585260.179-4,459.253-1,865.691-5,532.014-8,417.38-7,636.968-14,032.233-16,310.406-9,190.681-2,486.763-3,339.802-2,064.335
Bedrijfsresultaat ratio 0.0170.1470.150.1920.060.009-0.177-0.067-0.22-0.418-0.229-1.263-1.586-1.443-0.346-0.401-0.168
Totaal overige inkomsten en kosten netto 3,781.061-2,904.4091,902.722-1,991.577479.544-12,941.063-34,737.3591,188.979-858.199-20,351.057-18,063.995-2,647.436-3,277.156-4,641.897-1,446.927338.9091,156.474
Inkomen voor belasting 4,732.0575,968.9589,513.3385,241.8012,443.128-12,680.884-39,196.611-676.712-6,390.212-28,768.437-25,700.965-16,679.67-18,471.425-13,832.579-3,933.691-3,000.892-907.86
Inkomen voor belasting ratio 0.0840.0990.1870.1390.075-0.447-1.556-0.024-0.254-1.427-0.769-1.501-1.796-2.172-0.547-0.36-0.074
Belastingkosten 1,154.074-4,915.804377.717761.953-1,904-12,884.30634,395.9021,366.94-412.473-3,505.652-313.519969.804-285.469-3,535.66619.5222,278.871,773.289
Nettowinst 3,577.9848,261.7699,450.9075,241.8014,347.128-12,680.884-39,196.611-676.712-6,390.212-28,768.437-25,700.635-17,642.755-18,172.653-13,832.579-3,953.213-4,432.368-907.86
Nettowinstmarge 0.0640.1370.1860.1390.134-0.447-1.556-0.024-0.254-1.427-0.769-1.588-1.767-2.172-0.55-0.532-0.074
WPA (Winst Per Aandeel) 59.63137.79157.6687.4472.52-214-671.27-12-115.17-619-607.88-467-694.74-667.5-257.5-265.3-68.8
Verwaterde WPA 59.63137.79157.6687.4472.52-214-671.1-12-115-619-607.88-467-694.74-667.5-257.5-265.3-68.8
EBITDA 3,792.40413,684.30411,626.97,772.9844,388.4752,129.33633,262.4722,847.527-3,354.291-9,135.778-4,351.54-11,881.389-14,241.31-12,290.245-2,549.607-1,957.125443.66
EBITDA ratio 0.0670.2270.2280.2060.1350.0751.320.102-0.133-0.453-0.13-1.069-1.385-1.93-0.355-0.2350.036